Skip to main content
LOGIN
Solutions
Solutions
Solutions for Integrated Delivery Networks
Solutions for Community Cancer Centers
Solutions for Academic Institutions and NCI-Designated Cancer Centers
Solutions for Life Science
Resources
Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Schedule A Demo
Solutions
Driving Timely, Precision Cancer Care for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Enabling the Right Treatment at the Right Time for Every Cancer Patient
Explore the OncoLens Platform
Learn More
Resources
Project ECHO® Learning Series
Evolving Role of Bispecific Antibodies as Cancer Therapy
Join ACCC, Physicians' Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a five-part complimentary tele-mentoring series on the optimal use of bispecific antibodies as cancer immunotherapies.
VIEW RECORDED SESSIONS
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
3,000,000+
Oncology patients under care within the network
85-90%
Accuracy in AI-driven Patient ID from unstructured data
250,000+
Multidisciplinary case discussions
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule a Demo
Careers
Solutions
Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Next Level
Multidisciplinary Cancer Care
Explore the OncoLens Platform
Resources
Project ECHO® Learning Series
Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
LEARN MORE and REGISTER
Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
Powered by OncoLens.
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
2,000,000+
Patients under Care in 200+ Cancer Centers
118,000+
Multidisciplinary Case Discussions
19,000+
Comprehensive Tumor Conferences
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule A Demo
SCHEDULE A DEMO
LOGIN
Home
Resources
Education
Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results
Date Recorded:
February 1, 2021
Recording Length:
14:24
Topics:
lung cancer
,
NSCLC
Latest
Nov 6, 2024 | Blog
The Lung-MAP (NCTID:03851445) Trial: Early Patient Tracking for Improved Accruals
Read more
Oct 24, 2024 | News and Events
Oncology Health Tech Startup Announces Series B Funding Round for Continued Growth of Cancer Treatment Platform and Research Network
Read more
Sep 18, 2024 | News and Events
OncoLens Announces Real-Time Oncology Patient Identification for Clinical Trials and Key Services
Read more
Jul 10, 2024 | Case Studies
Enhancing Guideline-Based Genetic Testing in Breast Patients with OncoLens Advanced Patient ID
Read more
2934
